BioRestorative Therapies (BRTX) Interest Expense - Others (2015 - 2022)
BioRestorative Therapies' (BRTX) quarterly Interest Expense - Others came in at $46613.0 in Q2 2022, down 90.81% YoY from $507332.0 in Q2 2021, and up 60.67% on a QoQ basis from $29011.0 in Q1 2022.
BioRestorative Therapies (BRTX) Interest Expense - Others (2015 - 2022) Analysis & Trends
BioRestorative Therapies (BRTX) has 8 years of Interest Expense - Others data on file, last reported at $46613.0 in Q2 2022.
- Quarterly Interest Expense - Others fell 90.81% year-over-year to $46613.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $784984.0 (down 18.16% YoY) and the FY2021 annual result came in at $1.8 million, up 10.68% from the prior year.
- Interest Expense - Others climbed to $46613.0 in Q2 2022, from $29011.0 in the prior quarter.
- In the past five years, Interest Expense - Others ranged from a high of $507332.0 in Q2 2021 to a low of $24168.0 in Q2 2020.
- A 5-year average of $247464.3 and a median of $243840.5 in 2018 frame the typical range for Interest Expense - Others.
- Annual changes were most pronounced in 2020 — Interest Expense - Others plunged 92.63% — and 2021, when it jumped 1999.19%.
- Tracing BRTX's Interest Expense - Others over 5 years: stood at $283247.0 in 2018, then soared by 51.18% to $428225.0 in 2019, then tumbled by 46.83% to $227683.0 in 2020, then slipped by 6.09% to $213815.0 in 2021, then tumbled by 78.2% to $46613.0 in 2022.
- The last three Interest Expense - Others figures came in at $46613.0 (Q2 2022), $29011.0 (Q1 2022), and $213815.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BioRestorative Therapies | 2.00 Mn | -953,752.60 | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 46,613.00 |
| Mar 31, 2022 | 29,011.00 |
| Dec 31, 2021 | 213,815.00 |
| Sep 30, 2021 | 495,545.00 |
| Jun 30, 2021 | 507,332.00 |
| Mar 31, 2021 | 181,514.00 |
| Dec 31, 2020 | 227,683.00 |
| Sep 30, 2020 | 42,611.00 |
| Jun 30, 2020 | 24,168.00 |
| Mar 31, 2020 | 285,926.00 |
| Dec 31, 2019 | 428,225.00 |
| Sep 30, 2019 | 394,816.00 |
| Jun 30, 2019 | 327,967.00 |
| Mar 31, 2019 | 316,944.00 |
| Dec 31, 2018 | 283,247.00 |
| Sep 30, 2018 | 257,298.00 |
| Jun 30, 2018 | 230,383.00 |
| Mar 31, 2018 | 161,259.00 |
| Dec 31, 2017 | 160,701.00 |
| Sep 30, 2017 | 114,202.00 |